SEC Form 4 · accession 0001127602-16-036639
UNITED THERAPEUTICS Corp · UTHR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher Patusky
Director
Period of report
Jan 7, 2016
Accepted (ET)
Jan 8, 2016 · 4:43 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001082554
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 7, 2016 | M | 3,000 | $48.11 | A | 3,000 | D | |
| Common Stock | Jan 7, 2016 | D | 3,000 | $144.42 | D | 0 | D | |
| Common Stock | holding | — | — | — | 1,300 | I | By Family Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Share Tracking Award | $48.11 | Jan 7, 2016 | M | 3,000 | D | Jun 26, 2013 | Jun 26, 2022 | Common Stock | 3,000 | 12,000 | D |
Explanation of responses
- F1Exercise of a cash-settled share tracking award pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.